Three distinguished experts have joined InSilico Medicine

The Future of Aging and Aging Disease Prevention is Bright with the Growth of InSilico Medicine’s Scientific Advisory Board

Three distinguished experts have joined InSilico Medicine, including Donald Small, MD, PhD, Kristen Fortney, PhD and Alexey Moskalev, DSc.

InSilico Medicine proudly announces that Donald Small, MD, PhD, Kristen Fortney, PhD and Alexey Moskalev, DSc will aid the company’s mission to successful drug discovery and personalized medicine. It is clear meaningful progress is being made to battle aging from InSilico Medicine, considering the past major SAB additions.

For more information please see http://www.prweb.com/releases/2014/09/prweb12195460.htm

About InSilico Medicine

InSilico Medicine was founded in early 2014 and has since developed the OncoFinder and Geroscope. It is a company dedicated to finding novel solutions towards aging and age-related diseases using advances in genomics and big data analysis. Through internal expertise and extensive collaborations with brilliant scientists, institutions, and highly credible pharmaceutical companies, InSilico Medicine seeks to revolutionize personalized science and drug discovery. More can be read about InSilico Medicine, Inc. at http://www.insilicomedicine.com.